Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
| Episode | Date |
|---|---|
|
S2 Ep93: Insights from ESC: Treat Earlier, Implement Better, and Question What We Thought We Knew
|
Aug 31, 2026 |
|
S1 Ep37: ESC 2026 Hot Line Recap: 3 Trials Every Pharmacist Needs
|
Aug 28, 2026 |
|
S1 Ep36: 2026 ACC Consensus Pathway Redefines HFpEF Diagnosis, Treatment Priorities
|
Aug 05, 2026 |
|
S1 Ep35: Deprescribing in Cardiovascular Disease: A New AHA Roadmap for Tackling Polypharmacy
|
Jul 21, 2026 |
|
S1 Ep34: Putting the 2026 CKM Guidelines Into Practice: A Pharmacist's Perspective
|
Jun 24, 2026 |
|
S1 Ep33: Craig Beavers, PharmD Breaks Down the 2026 CKM Guidelines — And Why They Matter
|
Jun 10, 2026 |
|
S1 Ep32: What's Making Headlines in Cardiovascular Care: A Pharmacist's Breakdown of the Latest Breakthroughs
|
May 27, 2026 |
|
S1 Ep31: From Misdiagnosis to Advocacy: Addressing Bias and Equity in Heart Failure Management
|
May 12, 2026 |
|
S1 Ep30: Debriefing ACC 2026: Key Cardiovascular Trials and Their Clinical Implications for Pharmacists
|
Apr 28, 2026 |
|
S1 Ep29: New Dyslipidemia Guidelines Restore LDL Goals and Expand Pharmacist Opportunities
|
Mar 31, 2026 |
|
S1 Ep27: Pharmacists’ Evolving Role in Electrophysiology Takes Center Stage Ahead of ACC 2026
|
Mar 17, 2026 |
|
S1 Ep28: Unpacking the 2025 ACC/AHA Pulmonary Embolism Guidelines With a Thrombosis Pharmacist
|
Mar 03, 2026 |
|
S1 Ep27: Addressing Gaps in Secondary Stroke Prevention With Factor XIa Inhibition
|
Feb 17, 2026 |
|
S1 Ep26: Pharmacist-Led Strategies Offer Solutions to Ongoing Hypertension Control Failures
|
Feb 10, 2026 |
|
S1 Ep25: How the POLY-HF Trial Shows Pharmacists' Key Role in Heart Failure Care
|
Feb 03, 2026 |
|
S1 Ep24: Hypertrophic Cardiomyopathy: What Pharmacists Need to Know in 2026
|
Jan 20, 2026 |
|
S1 Ep23: Happy New Year from The Tell-Tale Heart!
|
Jan 06, 2026 |
|
S1 Ep22: From Diagnosis to Transplant: A Heart Failure Patient’s Journey and the Pharmacists’ Impact Along the Way
|
Dec 16, 2025 |
|
S1 Ep21: Breaking Down Celebrate and POLY-HF: Two Paths to Better Cardiac Care
|
Dec 02, 2025 |
|
S1 Ep20: Inside AHA’s Late-Breaking Lipid Trials: The Rise of Oral PCSK9 Inhibition
|
Nov 18, 2025 |
|
19: Jazzed Up for American Heart Association 2025 in New Orleans
|
Nov 04, 2025 |
|
S1 Ep18: The Adipokine Hypothesis and Inflammation: Explaining Pathogenesis and Guiding Treatment
|
Oct 21, 2025 |
|
S1 Ep17: New Frontiers in Hypertension Care: Insights from the KARDIA-3 and Bax Hypertension Trials
|
Oct 07, 2025 |
|
S1 Ep16: Deconstructing Meta-Analyses From ESC 2025
|
Sep 23, 2025 |
|
S1 Ep15: ESC 2025 Highlights: Insights on ALONE-AF and AQUATIC Trials
|
Sep 09, 2025 |
|
S1 Ep14: Sifting Through Discordant Data From ESC 2025
|
Sep 05, 2025 |
|
S1 Ep13: From Guidelines to Action: Pharmacy’s Role in Hypertension Management
|
Aug 26, 2025 |
|
S1 Ep12: A New Joint Scientific Statement and What to Watch for at the European Society of Cardiology Congress 2025
|
Aug 12, 2025 |
|
S1 Ep11: A Roundtable Discussion of Upcoming Hot Line Trials at ESC Congress 2025
|
Jul 29, 2025 |
|
S1 Ep10: COBRRA Trial Results Raise Questions About VTE Management
|
Jul 15, 2025 |
|
S1 Ep9: An Overview of Intravenous Iron in Heart Failure and the FAIR-HF2 Trial
|
Jul 01, 2025 |
|
S1 Ep8: Concierge Pharmacy's Role in Cardio-Kidney-Metabolic Health Care
|
Jun 17, 2025 |
|
S1 Ep7: New Programs Aim to Improve Implementation of Cardiovascular Interventions
|
Jun 02, 2025 |
|
S1 Ep6: Pharmacist Involvement in Clinical Research and the FINEARTS-HF Trial
|
May 20, 2025 |
|
S1 Ep5: Pharmacists Can Be At the Forefront of Cardio-Kidney-Metabolic Management
|
May 06, 2025 |
|
S1 Ep4: The RIVAWAR Trial and ACS Guidelines for LV Thrombus
|
Apr 22, 2025 |
|
S1 Ep3: Updates to Acute Coronary Syndrome Guidelines
|
Apr 08, 2025 |
|
S1 Ep2: Everything You Need to Know from the American College of Cardiology 2025 Scientific Session
|
Apr 01, 2025 |
|
S1 Ep1: Introducing the Tell-Tale Heart Podcast
|
Mar 25, 2025 |